Nostics
Founded 2020 · 31 employees on LinkedIn · 1 known investors
Nostics develops a portable optical biosensor that measures real-time spectral signals from pathogens in patient samples, using its Spectral Foundation Model to identify infections at the point of care in under 10 minutes. The platform targets healthcare providers seeking rapid, lab-comparable infection diagnostics for decentralized settings and to address antimicrobial resistance.
Founders & leadership
Nostics was founded in 2020 by Rochelle Niemeijer.
RN
Rochelle NiemeijerCo-founder
JN
Jeroen NieuwenhuisCEO
Investors · 1
Frequently asked questions
- What does Nostics do?
- Nostics develops a portable optical biosensor that measures real-time spectral signals from pathogens in patient samples, using its Spectral Foundation Model to identify infections at the point of care in under 10 minutes. The platform targets healthcare providers seeking rapid, lab-comparable infection diagnostics for decentralized settings and to address antimicrobial resistance.
- Who founded Nostics?
- Nostics was founded by Rochelle Niemeijer in 2020.
- Who are Nostics's investors?
- Nostics's investors include DFF Ventures.